A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
Clinical trial NCT07227636 · RECRUITING
Trial details
- NCT number
- NCT07227636
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-07
- Primary completion
- 2030-11-01
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.